Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

Van Andel Institute

Tracked across 2 events · 12 articles · First seen Apr 15, 2026 · Last active Sep 23, 2026

Sentiment
40
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 70
Tech
Impact: Van Andel Institute is a key institution in this event, as its scientists, including Hong Li, co-led the research and analyzed ThermoCas9's structure, demonstrating its ability to selectively target tumor DNA.
Apr 15, 2026 · 6 articles
1 10
Tech
The phase 2 EVITA trial, a randomized, double-blind, placebo-controlled study, tested whether high-dose oral vitamin C (1000 mg/day for 12 months) could benefit patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies, conditions…
Impact: Co-led the EVITA trial through its VAI-SU2C Epigenetics Dream Team and provided co-senior author Peter A. Jones; the positive exploratory signal enhances its research reputation.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Van Andel Institute live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.